Corporate Risk Management by Indian Pharmaceutical Companies: A Comprehensive Literature Review
International Journal of Global Business and Competitiveness · 2026-09 · 21 (2) · 146-155
DOI: 10.1007/s42943-026-00159-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Global Business and Competitiveness, online erschienen am 26.08.2026. Verfasst von Jaykumar G. Parmar und 1 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Parmar, J. G., & Dalvadi, Y. M. (2026). Corporate Risk Management by Indian Pharmaceutical Companies: A Comprehensive Literature Review. International Journal of Global Business and Competitiveness, 21(2), 146-155. https://doi.org/10.1007/s42943-026-00159-8
Vancouver
Parmar JG, Dalvadi YM. Corporate Risk Management by Indian Pharmaceutical Companies: A Comprehensive Literature Review. International Journal of Global Business and Competitiveness. 2026;21(2):146-155. doi:10.1007/s42943-026-00159-8
BibTeX
@article{Parmar2026,
author = {Parmar, Jaykumar G. and Dalvadi, Yagnesh M.},
title = {Corporate Risk Management by Indian Pharmaceutical Companies: A Comprehensive Literature Review},
journal = {International Journal of Global Business and Competitiveness},
year = {2026},
volume = {21},
number = {2},
pages = {146--155},
doi = {10.1007/s42943-026-00159-8}
}
EUVIMED